Pharmafile Logo
  • - PMLiVE
  • - PMLiVE
  • Diversity, Equity and Inclusion
  • Communiqué 53 Cover Image

The Trust Test

Office move signals new era for Berkshire agency

Dice Medical Communications moves office due to business growth

Dice Medical Communications

How Ease of Access to HES Data Benefits HCPs & Key NHS Stakeholders

Article written August 27th 2021

Dice Medical Communications

How a Copywriter Reads a Clinical Paper

What key elements you need to consider in a clinical paper (Article written November 18th 2021)

Dice Medical Communications

What does HCP engagement look like in a post-Covid world?

HCP engagement has changed as a result of the Covid-19 pandemic, with pharmaceutical companies and agencies having to rapidly adjust to a new way of communicating. Digital channels have become...

Dice Medical Communications

Placing people at Lucid’s heart: Paul Cutler, Lucid Group’s new Chief People Officer

We interviewed Paul Cutler, Lucid Group’s new Chief People Officer, to find out a bit more about what makes him tick, why he chose to join Lucid, and what his...

Lucid Group Communications Limited

- PMLiVE

AbbVie acquires Syndesi Therapeutics in $1bn deal

The deal will allow AbbVie to access Syndesi’s research into Alzheimer's disease

- PMLiVE

Verily Life Science signs new contract with Oncimmune for long COVID study

The project will analyse potential patterns of autoantibodies, which are associated with developing long COVID

- PMLiVE

Nucleus Global launches new branding as it sets its sights on the future

Nucleus Global, the largest specialist medical communications network in the world, has announced the launch of its new brand.With over 35 years of experience providing medical communications excellence to the...

Nucleus Global

White paper: Are we prepared for the influx of CAR-Ts?

Download this white paper, in which we look at how market access and hospital processes will need to transform to accommodate the the influx of CAR-T therapies

Inizio

- PMLiVE

NHS trusts set a 90% target for electronic patient records by UK health secretary

Current estimates indicate that one in five NHS trusts still do not have electronic patient records

- PMLiVE

Janssen and Legend Biotech’s Carvykti receives FDA approval for patients with relapsed or refractory multiple myeloma

In the study, 98% of patients with relapsed or refractory multiple myeloma responded to a one-off treatment of the drug

- PMLiVE

Merck KGaA’s Glucophage approved in Europe as first oral diabetic medication for use during pregnancy

The oral drug offers comparable maternal blood sugar control to insulin, which needs to be injected

Subscribe to our email news alerts

Latest content

Latest intelligence

Quick links